XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.22.1

Shareholders' Equity (Deficit): | 3 Months Ended
--- | ---
Mar. 26, 2022
Shareholders' Equity (Deficit): |
Shareholders' Equity (Deficit): | 7. Shareholders’ Equity (Deficit): ​ Dividends ​ On January 26, 2022, the Company’s Board of Directors approved the payment of a $0.45 per share quarterly cash dividend to shareholders of record at the close of business on February 9, 2022, which was paid on March 1, 2022. ​ Repurchase of Common Stock ​ In the first three months of 2022, the Company repurchased 164,586 shares of its common stock. Under the Board of Directors’ authorization, as of March 26, 2022, the Company has the ability to repurchase an additional 140,179 shares of its common stock. Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing. ​ Stock Option Plans and Stock-Based Compensation ​ Stock option activity under the Company’s option plans as of March 26, 2022 was as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Weighted Average |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Remaining | ​ | ​ | ​
​ | ​ | Number of | ​ | Weighted Average | ​ | Contractual Life | ​ | ​ | ​
​ |  | Shares |  | Exercise Price |  | (years) |  |  | Intrinsic Value
Outstanding, December 25, 2021 |  | 355,621 | ​ | $ | 146.03 | ​ | 6.32 | ​ | $ | 39,320,600
Granted |  | 1,500 | ​ | ​ | 212.18 | ​ | ​ | ​ | ​ | ​
Exercised |  | (9,156) | ​ | ​ | 137.43 | ​ | ​ | ​ | ​ | ​
Outstanding, March 26, 2022 |  | 347,965 | ​ | $ | 146.54 | ​ | 6.09 | ​ | $ | 28,959,900
Exercisable, March 26, 2022 |  | 212,610 | ​ | $ | 113.96 | ​ | 4.48 | ​ | $ | 23,874,000
​ The fair value of options granted under the Option Plans during the first three months of 2022 and 2021 were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions and results: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | ​
​ |  | March 26, 2022 | ​ | March 27, 2021 | ​ |
Risk free interest rate |  | ​ | 1.88 | % | ​ | 0.64 | % |
Expected life (years) |  | ​ | 6 | ​ | ​ | 6 | ​ |
Expected volatility |  | ​ | 26.64 | % | ​ | 25.05 | % |
Dividend yield |  | ​ | 4.21 | % | ​ | 2.77 | % |
Option fair value | ​ | $ | 33.92 | ​ | $ | 30.02 | ​ | ​
​ ​ All unexercised options at March 26, 2022 have an exercise price equal to the fair market value on the date of the grant. ​ Compensation expense of $421,600 and $385,200 relating to the vested portion of the fair value of stock options granted was expensed to “Selling, General and Administrative Expenses” in the first three months of 2022 and 2021, respectively. As of March 26, 2022, the Company had $3.6 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 2.6 years.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration